Optimal dosing of ofloxacin with loperamide in the treatment of non-dysenteric travelers' diarrhea

Journal of Travel Medicine

Volumn 8, Issue 4, 2001, Pages 207-209

  Ericsson, Charles D ^a,d   DuPont, Herbert L ^b   Mathewson, John J ^c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c Houston City Health/Human Svcs Dept   (United States)

^d 1722 John Freeman Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; COTRIMOXAZOLE; LOPERAMIDE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; TRAVEL; TRAVELLER DIARRHEA; TREATMENT OUTCOME;

EID: 0035204380     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2001.24244     Document Type: Article

References (6)

1. Treatment of travelers' diarrhea with sulfamethoxazole and trimethoprim and loperamide
2. Optimal dosing of trimethoprim/sulfamethoxazole when used with loperamide to treat travelers' diarrhea
3. Single dose ofloxacin plus loperamide compared with single dose or three days of ofloxacin in the treatment of travelers' diarrhea
4. Travelers' diarrhea: Epidemiology, prevention, and self-treatment
5. Travelers' diarrhea: Epidemiology, microbiology, prevention, and therapy
6. Rifaximin, a nonabsorbed antimicrobial, in the therapy of travelers' diarrhea